Arkolith/Insider Trading/ANEB/Form 4

English Aron R.

Director, 10% OwnerAnebulo Pharmaceuticals, Inc. (ANEB) · full profile →Form 4 · filed Sep 30, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 28, 2022Grant(A)1.7M$2.81$4.8M5.1M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 28, 2022Grant(A)1.7M$0.13$221K1.7M
Apr 21, 2022Grant(A)30K—$030K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-051688) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML